OpenAI Nears $100B Valuation in New Funding Round
OpenAI is reportedly closing in on a new funding round that would value the company at $100 billion, with SoftBank, Amazon, and Nvidia among the anticipated investors. Box CEO Aaron Levie commented that the AI market will be significantly larger than expected, with room for several companies to reach multi-trillion dollar valuations. The massive investment signals a new epoch in technology centered on artificial intelligence.
- OpenAI’s valuation has grown dramatically, from an estimated $29 billion in early 2023 to a reported $500 billion following a secondary share sale in October 2025. Microsoft is a key partner, having invested over $13 billion and recently holding a stake valued at approximately $135 billion. - The competitive landscape for large-scale AI models is intensifying, with rival Anthropic raising $30 billion at a $380 billion valuation in February 2026, and French competitor Mistral AI reaching a valuation of over $14 billion. - This flood of capital into AI is reshaping the digital health sector, where startups leveraging AI for applications like drug discovery and personalized medicine are securing larger and more frequent funding rounds; in 2025, AI-powered digital health companies raised financing rounds that were, on average, 83% larger than their non-AI counterparts. - For consumer health apps, AI is primarily used to analyze user-inputted data and real-time readings from wearables (via APIs for Apple HealthKit, Fitbit, etc.) to generate personalized health plans, predict potential health issues, and identify early signs of disease. - While health apps that collect information directly from consumers generally fall outside HIPAA's scope, they are subject to other regulations like the FTC's Health Breach Notification Rule and a growing number of state-level privacy laws. - States like Washington, Nevada, and Connecticut have enacted specific health data privacy laws that require companies to get explicit "opt-in" consent from consumers before collecting or sharing their health data, a stricter standard than HIPAA for some use cases. - Early-stage fundraising in digital health remains robust, with seed, Series A, and Series B rounds making up 83% of deals in the first quarter of 2025. The average deal size in that quarter jumped to $24.4 million, up from $15.5 million in the fourth quarter of 2024.
